绿帽社

How big is the Continuous Glucose Monitoring Device Market | Share 2025

Code: MTA5195 Publication Date: Jul 2025

What is the Continuous Glucose Monitoring Device Market Size?

According to 绿帽社 internal database and industry insights, the Global Continuous Glucose Monitoring Device market was valued at USD 5 billion in 2024 and is anticipated to exceed USD 12.5 billion by 2031, registering a steady at a CAGR of 9% during the forecast period.

The Continuous Glucose Monitoring Device market is driven by factors such as rising diabetes cases, real-time monitoring demand, tech innovation, preventive care focus, reimbursement support, and digital health integration drive growth. Implementation in the fitness and wellness industries, together with support for reimbursement, helps the industry develop even further.

Major Growth Factors of the Continuous Glucose Monitoring Device Industry

  • Rapid advancements in sensor miniaturization and accuracy
  • Surge in diabetes diagnoses worldwide
  • Increase in health-conscious and fitness-driven users
  • Expansion of insurance reimbursement policies
  • Integration with insulin delivery and telehealth systems
  • Growth of home healthcare settings
  • Shift toward non-invasive and remote monitoring
  • Regulatory approvals for OTC devices

Continuous Glucose Monitoring Device Market Trends

Continuous Glucose Monitoring Device market is going to witness a massive move toward hybrid wearables that track both glucose levels and exercise levels, giving you a more complete picture of your health. Gradually people want optical sensors that don't require surgery and apps that work together without any problems. Moreover, CGMs are being combined with telemedicine platforms and AI-driven analytics to get users more involved and help doctors make better decisions.

Emerging Developments in the Continuous Glucose Monitoring Device Industry

Continuous Glucose Monitoring Device market is evolving with great progress in non-invasive technologies; such optical or sweat-based sensors built into smartwatches. More and more closed-loop solutions are being made that connect CGMs to insulin pumps that work on their own. Also, AI-powered prediction warnings and real-time data sharing are becoming more popular for easy remote monitoring.

Major Companies in the Continuous Glucose Monitoring Device Industry

  • Dexcom
  • Abbott Laboratories
  • Medtronic
  • Roche
  • Senseonics
  • Nemaura Medical
  • Ypsomed
  • LifeScan
  • F. Hoffmann-La Roche
  • B. Braun
How big is the Continuous Glucose Monitoring Device Market : FAQ's
The Continuous Glucose Monitoring Device market was valued around USD 5鈥痓illion in 2024, with a CAGR of roughly 9% toward 2031.
The Continuous Glucose Monitoring Device market is expected to grow to approximately USD 12.5鈥痓illion by 2031.
Continuous Glucose Monitoring Device market includes major factors such as rise in diabetes prevalence, better sensor tech, move toward non-invasive use, and growing wellness applications.
Continuous Glucose Monitoring Device market is having challenges such as high upfront cost for uninsured patients, inadequate awareness in low-income regions, and sensor lifespan and skin irritation in some users due to which the growth of the market can be hampered.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
绿帽社 Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All